You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bicalutamide

Showing 51 - 75 of 240
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Hormone-Dependent Prostate Cancer Trial in Worldwide (SHR3680, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Hormone-Dependent Prostate Cancer
  • Burgas, Bulgaria
  • +66 more
Feb 28, 2021

Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)

Recruiting
  • Breast Cancer
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin School of Medicine and Public Health
Oct 18, 2022

Prostate Cancer Trial in Shanghai (Bicalutamide, goserelin acetate, flutamide)

Active, not recruiting
  • Prostate Cancer
  • Bicalutamide
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 5, 2020

Prostate Cancer Trial in Japan (Enzalutamide, Flutamide, Androgen deprivation therapy)

Completed
Has Results
  • Prostate Cancer
  • Nagoya, Aichi, Japan
  • +46 more
May 18, 2021

Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • (no location specified)
Nov 10, 2023

Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in United Kingdom (Radical therapy (radiotherapy

Recruiting
  • Prostate Cancer
  • +2 more
  • Radical therapy (radiotherapy or prostatectomy [radiotherapy can be external beam or brachytherapy]
  • +3 more
  • Brixton, London, United Kingdom
  • +9 more
Apr 16, 2021

Prostate Cancer Trial in Houston (Flutamide, Leuprolide Acetate)

Terminated
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
Apr 20, 2020

Prostate Cancer Trial in United States (Apalutamide, LHRH Analogue, Abiraterone Acetate)

Active, not recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +68 more
Nov 28, 2022

Prostate Cancer Trial in United States (Ibrance, Bicalutamide, Zoladex)

Completed
Has Results
  • Prostate Cancer
  • Duarte, California
  • +7 more
Aug 28, 2020

Prostatic Tumors Trial in Japan (Androgen-deprivation Therapy (ADT), Bicalutamide, Abiraterone)

Active, not recruiting
  • Prostatic Neoplasms
  • Androgen-deprivation Therapy (ADT)
  • +6 more
  • Akita, Japan
  • +76 more
Jan 19, 2023

Prostate Cancer Trial in United States (bicalutamide, goserelin, mitoxantrone HCl)

Completed
Has Results
  • Prostate Cancer
  • bicalutamide
  • +3 more
  • Anchorage, Alaska
  • +233 more
Dec 5, 2022

Prostate Cancer Trial in United States (Androgen deprivation therapy (ADT), Brachytherapy, Hypofractionated pelvic External beam

Recruiting
  • Prostate Cancer
  • Androgen deprivation therapy (ADT)
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 2, 2022

Prostate Cancer Trial in Sherbrooke (Androgen blockade + radiation therapy)

Active, not recruiting
  • Prostate Cancer
  • Androgen blockade + radiation therapy
  • Sherbrooke, Quebec, Canada
    Centre de Recherche Clinique du CHUS
May 20, 2022

Prostatic Tumors Trial in Worldwide (Antiandrogen, Antiandrogen+docetaxel)

Active, not recruiting
  • Prostatic Neoplasms
  • Copenhagen, Denmark
  • +4 more
Aug 12, 2021

Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • triptorelin, goserelin, leuprorelin
  • (no location specified)
Mar 10, 2023

Prostatic Tumor Trial in Rome (salvage SBRT)

Recruiting
  • Prostatic Neoplasm
  • salvage SBRT
  • Rome, Italy
    Regina Elena National Cancer Institute
Dec 19, 2022

Prostate Cancer Trial in Canada (drug, procedure, radiation)

Terminated
  • Prostate Cancer
  • bicalutamide
  • +8 more
  • Calgary, Canada
  • +12 more
Mar 31, 2020

Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial (Bicalutamide, Laboratory Biomarker Analysis,

Withdrawn
  • Stage I Prostate Adenocarcinoma
  • Stage II Prostate Adenocarcinoma
  • Bicalutamide
  • +3 more
  • (no location specified)
Jan 17, 2019

Prostate Cancer Trial in Canada (bicalutamide, buserelin, cyproterone acetate)

Completed
  • Prostate Cancer
  • bicalutamide
  • +6 more
  • Calgary, Alberta, Canada
  • +28 more
Jun 21, 2021

Prostatic Tumors Trial in Guangzhou (Tcm+ Goserelin acetate+ Bicalutamide, Tcm+Goserelin acetate+Abiraterone acetate)

Unknown status
  • Prostatic Neoplasms
  • Tcm+ Goserelin acetate+ Bicalutamide
  • Tcm+Goserelin acetate+Abiraterone acetate
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Chinese Medicine, Guangzhou Uni
Jul 30, 2019

Prostate Cancer Trial in Paris (Leuprorelin, Bicalutamide)

Completed
Has Results
  • Prostate Cancer
  • Paris, France
  • +1 more
Jun 19, 2019

Prostate Cancer Trial in Hamburg (Radical prostatectomy, Best systemic therapy)

Active, not recruiting
  • Prostate Cancer
  • Radical prostatectomy
  • Best systemic therapy
  • Hamburg, Nein, Germany
    Markus Graefen
May 6, 2022

Prostate Cancer Trial (PSMA-radioguided surgery, ADT)

Not yet recruiting
  • Prostate Cancer
  • PSMA-radioguided surgery
  • ADT
  • (no location specified)
Sep 22, 2022

Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Canada, Puerto

Active, not recruiting
  • Stage I Prostate Adenocarcinoma
  • +2 more
  • Bicalutamide
  • +7 more
  • Mobile, Alabama
  • +313 more
Sep 7, 2022

Recurrent Prostate Cancer Trial in Bern (Ultrahypofractionated salvage radiotherapy to a local recurrence after radical

Recruiting
  • Recurrent Prostate Cancer
  • Ultrahypofractionated salvage radiotherapy to a local recurrence after radical prostatectomy
  • Androgen deprivation therapy
  • Bern, Switzerland
    Inselgruppe AG, Inselspital
Mar 1, 2023